Correlation Between Mereo BioPharma and Histogen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Histogen, you can compare the effects of market volatilities on Mereo BioPharma and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Histogen.

Diversification Opportunities for Mereo BioPharma and Histogen

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Mereo and Histogen is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Histogen go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Histogen

Given the investment horizon of 90 days Mereo BioPharma Group is expected to generate 0.19 times more return on investment than Histogen. However, Mereo BioPharma Group is 5.37 times less risky than Histogen. It trades about -0.22 of its potential returns per unit of risk. Histogen is currently generating about -0.3 per unit of risk. If you would invest  420.00  in Mereo BioPharma Group on August 29, 2024 and sell it today you would lose (80.00) from holding Mereo BioPharma Group or give up 19.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Mereo BioPharma Group  vs.  Histogen

 Performance 
       Timeline  
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Histogen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Histogen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Mereo BioPharma and Histogen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo BioPharma and Histogen

The main advantage of trading using opposite Mereo BioPharma and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.
The idea behind Mereo BioPharma Group and Histogen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
FinTech Suite
Use AI to screen and filter profitable investment opportunities